Home
>
US Stocks
>
Precision Biosciences Inc
Precision Biosciences Inc
DTIL

Precision Biosciences Inc

$9.799.94%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
10.29
Today Low/High
9.71 / 10.29
52 Week Low/High
$4.46 / $16.6
Market Cap
$558.84M

Company Details

Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its wholly proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company's pipeline consists of multiple 'off-the-shelf' CAR T immunotherapy clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist.
Organisation
Precision Biosciences Inc
Headquaters
Durham, North Carolina, United States
Employees
231
Industry
Biotechnology
CEO
Matthew Kane

Discover more

Frequently Asked Questions

What is Precision Biosciences Inc share price today

Can Indians buy Precision Biosciences Inc shares?

How can I buy Precision Biosciences Inc shares from India?

Can Fractional shares of Precision Biosciences Inc be purchased?

What are the documents required to start investing in Precision Biosciences Inc stocks?

We are a SEBI registered investement advisor